Drug Research
The User Fees Have Been Authorised Yet Again At The FDA
As anticipated, four important user fee programmes were renewed by Congress for the week ending October 1st as part of a bill that was required to pass in order to finance the government for yet another two months. By...
Drug Research
Junk DNA Could Be The Key To Understanding Neuro Ailments
According to recent studies, there is a connection between non-coding DNA and some neurological diseases such as Alzheimer's and motor neurone disease.
Researchers from the Universities of Sheffield and Lincoln studied how oxidative breaks in so-called junk DNA are created...
Drug Research
To Accredit Medical Devices In The UK, MHRA Selects DEKRA
The three current UK-approved bodies have been joined by DEKRA Certification UK, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), enhancing the UK's capacity to handle conformity evaluations for medical devices. As the first institution to accomplish...
Drug Research
FDA Expanding Patient Participation In Drug Development
The FDA started a programme ten years ago to increase the role of patients in educating sponsors and regulators on the most detrimental impacts of a condition and the main treatment objectives that can result in desired medical methods....
Drug Research
Indian Biotech Regulatory Processes Must Be Ramped Up- Study
According to a report by the Indian industry group CII, there is a need to expedite regulatory processes and eliminate unnecessary stages to speed up the clearance process for the biotechnology industry as any delay in product introduction results...
Drug Research
NIH Research Links COVID Vaccine To Menstrual Cycle Length
An extensive worldwide study supported by the National Institutes of Health found a modest increase in the length of a woman's menstrual cycle after receiving the COVID-19 vaccine, which delayed the onset of bleeding by a few hours.
The NIH's...
Drug Research
Roche Commits $70M To Fill A Therapy Gap For Cancer Cells
A private biotechnology startup called Arsenal Biosciences will receive $70 million from Roche in exchange for access to technology that the two businesses believe will enable them to reroute immune cells to attack cancer.
According to the agreement, which was...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















